Imelda Miranda Mata

Imelda Mata practices at Hodari MD Dermatology in Yuba City, California.

Imelda Mata's NPI, 1134731268, was assigned on August 19, 2020. Imelda Mata holds California license 56624.

Imelda Mata's primary practice is Hodari MD Dermatology, at 1178 Live Oak Blvd, Yuba City, CA 95991 in Sutter County. The practice phone is (530) 342-3686.

Imelda Mata's primary practice is Hodari MD Dermatology in Yuba City, California. Imelda Mata is also affiliated with Oroville Hospital. The medical group on file is Hodari MD Dermatology & Rejuvené. Dmand AI also links Imelda Mata to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Imelda Mata practices, 3 sites in all. Vendor and product names are available with a free account.

Physician assistant is Imelda Mata's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Imelda Mata is licensed in California.

Dmand AI lists acne, acute skin infection, ankle or foot injury, anxiety, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis and head wound among the conditions Imelda Mata treats.

CMS data shows 6,516 Medicare services from Imelda Mata across 26 procedure codes in 2024, for 839 Medicare patients. Medicare paid $277,724 for them. Every service was in an office.

CMS counts 839 Medicare patients who saw Imelda Mata in 2024. The largest group is 65 to 74, with 442 patients. 74% of them have high cholesterol, and 64% have high blood pressure. 12% are also on Medicaid. Their average risk score is 0.86, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Imelda Mata's median patient age at 67, with 52% women.

In 2024, Imelda Mata wrote 838 Medicare Part D claims for 354 patients. 97% of them were for generic drugs. CMS names the drug for 790 of them, across 18 drugs with 11 or more claims each, at $21,350 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Imelda Mata for performance year 2024, reported as part of a group. Imelda Mata accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 159 general payments to Imelda Mata from 13 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 92% of the total. Abbvie Inc. paid the most, $1,003.